HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

The elastin peptide VGVAPG increases CD4+ T-cell IL-4 production in patients with chronic obstructive pulmonary disease

Abstract : Background: In chronic obstructive pulmonary disease (COPD), lung-infiltrating inflammatory cells secrete proteases and participate in elastin breakdown and genesis of elastin-derived peptides (EP). In the present study, we hypothesized that the pattern of T lymphocytes cytokine expression may be modulated by EP in COPD patients. Methods: CD4 + and CD8 + T-cells, sorted from peripheral blood mononuclear cells (PBMC) collected from COPD patients (n = 29) and controls (n = 13) were cultured with or without EP. Cytokine expression in T-cell phenotypes was analyzed by multicolor flow cytometry, whereas desmosine concentration, a specific marker of elastin degradation, was measured in sera. Results: Compared with control, the percentage of IL-4 (Th2) producing CD4 + T-cells was decreased in COPD patients (35.3 ± 3.4% and 26.3 ± 2.4%, respectively, p < 0.05), whereas no significant differences were found with IFN-γ (Th1) and IL-17A (Th17). Among COPD patients, two subpopulations were observed based on the percentage of IL-4 (Th2) producing CD4 + T-cells, of which only one expressed high IL-4 levels in association with high levels of desmosine and strong smoking exposure (n = 7). Upon stimulation with VGVAPG, a bioactive EP motif, the percentage of CD4 + T cells expressing IL-4 significantly increased in COPD patients (p < 0.05), but not in controls. The VGVAPGinduced increase in IL-4 was inhibited in the presence of analogous peptide antagonizing VGVAPG/elastin receptor (S-gal) interactions. Conclusions: The present study demonstrates that the VGVAPG elastin peptide modulates CD4 + T-cells IL-4 production in COPD. Monitoring IL-4 in circulating CD4 + T-cells may help to better characterize COPD phenotypes and could open a new pharmacologic opportunity through CD4 + T-cells stimulation via the VGVAPG/S-gal receptor in order to favor an anti-inflammatory response in those COPD patients.
Document type :
Journal articles
Complete list of metadata

Contributor : Valerian Dormoy Connect in order to contact the contributor
Submitted on : Tuesday, March 16, 2021 - 12:10:48 PM
Last modification on : Thursday, October 14, 2021 - 1:10:15 PM
Long-term archiving on: : Thursday, June 17, 2021 - 7:26:33 PM


Publisher files allowed on an open archive




Flora Lemaire, Sandra Audonnet, Jeanne-Marie Perotin, Pierre Gaudry, Sandra Dury, et al.. The elastin peptide VGVAPG increases CD4+ T-cell IL-4 production in patients with chronic obstructive pulmonary disease. Respiratory Research, BioMed Central, 2021, 22 (1), ⟨10.1186/s12931-020-01609-4⟩. ⟨hal-03170597⟩



Record views


Files downloads